Table of Contents Table of Contents
Previous Page  794 / 1119 Next Page
Information
Show Menu
Previous Page 794 / 1119 Next Page
Page Background

Clinical radiobiology

All models are wrong, but some are useful

(David R. Wigg)

LQ-model has proven to be a useful tool for radiobiological calculations in

brachytherapy:

Fowler JF. Dose reduction factors when increasing dose rate in LDR or MDR brachytherapy of carcinoma of the

cervix.

Radiother Oncol 1997;45:49-54.

Dale RG et al. Calculation of integrated biological response in brachytherapy. Int J Radiat Oncol Biol Phys

1997;38:633-642.

Nag S, et al. A simple method of obtaining equivalent doses for use in HDR brachytherapy. Int J Radiat Oncol

Biol Phys

2000;46:507-513.

Lang S, et al. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total

dose constraints. Int J Radiat Oncol Biol Phys 2007;69:619-627

The effect of alternative biological modelling parameters (a/b and half time of repair T1/2) on reported EQD2

values in the treatment of advanced cervical cancer. De Leeuw 2011 Radiother Oncol Nov 101(2) 337-42

Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose

adding for patients with cervical cancer Van de Kamer 2010, RaditherOncol 94;248-253

Despite all limitations and simplifications, the LQ-model can be used

for treatment planning and reporting